Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dione Gardner-Stephen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Mediators of Inflammation|June 14, 2016
Targeting Endothelial Adhesion Molecule Transcription for Treatment of Inflammatory Disease: A Proof-of-Concept StudyLiam M Ashander, Binoy Appukuttan, Yuefang Ma, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 27, 2005
Human UDP-glucuronosyltransferase 1A5: identification, expression, and activityMoshe Finel, Xin Li, Dione Gardner-Stephen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 25, 2004
Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecidVerawan Uchaipichat, Peter I Mackenzie, Xiao-Hui Guo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 24, 2004
Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expressionDione Gardner-Stephen, Jean-Marie Heydel, Amit Goyal, et al.
Molecular Pharmacology|July 15, 2010
A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronideDong Gui Hu, Dione Gardner-Stephen, Gianluca Severi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Mediators of Inflammation|June 14, 2016
Targeting Endothelial Adhesion Molecule Transcription for Treatment of Inflammatory Disease: A Proof-of-Concept StudyLiam M Ashander, Binoy Appukuttan, Yuefang Ma, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 27, 2005
Human UDP-glucuronosyltransferase 1A5: identification, expression, and activityMoshe Finel, Xin Li, Dione Gardner-Stephen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 25, 2004
Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecidVerawan Uchaipichat, Peter I Mackenzie, Xiao-Hui Guo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 24, 2004
Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expressionDione Gardner-Stephen, Jean-Marie Heydel, Amit Goyal, et al.
Molecular Pharmacology|July 15, 2010
A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronideDong Gui Hu, Dione Gardner-Stephen, Gianluca Severi, et al.
Pageof 1